ERBB2 and familial pancreatic carcinoma: Similar to miR-488 overexpression, ERBB2 knockdown in pancreatic cancer cells attenuated the cancer cell malignancy by inhibiting the cell viability, promoting cell apoptosis, and eliciting cell cycle G2/M-phase arrest.